Search by Drug Name or NDC
NDC 24208-0464-15 BRINZOLAMIDE 10 mg/mL Details
BRINZOLAMIDE 10 mg/mL
BRINZOLAMIDE is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BRINZOLAMIDE.
MedlinePlus Drug Summary
Ophthalmic Brinzolamide is used to treat glaucoma, a condition that increases pressure in the eye and leads to vision loss. Brinzolamide is in a class of medications called carbonic anhydrase inhibitors. It decreases the pressure in the eye.
Related Packages: 24208-0464-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Brinzolamide Ophthalmic
Product Information
| NDC | 24208-0464 |
|---|---|
| Product ID | 24208-464_9702bb56-cb22-450f-bb4c-a5a7714774a3 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | BRINZOLAMIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | brinzolamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | BRINZOLAMIDE |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204884 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0464-15 (24208046415)
| NDC Package Code | 24208-464-15 |
|---|---|
| Billing NDC | 24208046415 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (24208-464-15) / 15 mL in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2022-03-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |